Skip to main content

2 Result(s)

within Article Remove this filter Shi-liang Liu Remove this filter Health Promotion and Disease Prevention Remove this filter

and

  1. Article

    Open Access

    Comparative efficacy and safety of immunotherapy for patients with advanced or metastatic esophageal squamous cell carcinoma: a systematic review and network Meta-analysis

    The study aimed to compare efficacy and safety of various immune checkpoint inhibitors for patients with advanced or metastatic esophageal squamous cell carcinoma (ESCC).

    Tian-Tian Gao, Jia-Hui Shan, Yu-**an Yang, Ze-Wei Zhang, Shi-Liang Liu… in BMC Cancer (2022)

    Download PDF (1679 KB) View Article

  2. Article

    Open Access

    Optimize the dose of oxaliplatin for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy followed by radical surgery and adjuvant chemotherapy

    Addition of oxaliplatin to capecitabine remains controversial for locally advanced rectal cancer (LARC). And cumulative oxaliplatin dose (COD) varied among clinical trials showing different therapeutic effects...

    Hui Chang, Ya-lan Tao, Wu Jiang, Chen Chen, Shi-liang Liu, Wei-jun Ye… in BMC Cancer (2020)

    Download PDF (1521 KB) View Article